These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15531941)

  • 21. Role of electrocardiography in identifying right ventricular dysfunction in acute pulmonary embolism.
    Punukollu G; Gowda RM; Vasavada BC; Khan IA
    Am J Cardiol; 2005 Aug; 96(3):450-2. PubMed ID: 16054481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-dimer level is not a prognostic biomarker specific of pulmonary embolism.
    Kabbara R; Labarere J; Pernod G; Bosson JL
    Crit Care Med; 2008 Feb; 36(2):652-3; author reply 653. PubMed ID: 18216635
    [No Abstract]   [Full Text] [Related]  

  • 23. Thrombolysis for pulmonary embolism in patients with right ventricular dysfunction: con.
    Thabut G; Logeart D
    Arch Intern Med; 2005 Oct; 165(19):2200-3; discussion 2204-5. PubMed ID: 16246981
    [No Abstract]   [Full Text] [Related]  

  • 24. [The potential of new and old biomarkers for risk stratification in pulmonary embolism].
    Robalo Martins S
    Rev Port Cardiol; 2011 Dec; 30(12):887-9. PubMed ID: 22094309
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis.
    Becattini C; Vedovati MC; Agnelli G
    Circulation; 2007 Jul; 116(4):427-33. PubMed ID: 17606843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarker-based risk assessment model in acute pulmonary embolism.
    Kostrubiec M; Pruszczyk P; Bochowicz A; Pacho R; Szulc M; Kaczynska A; Styczynski G; Kuch-Wocial A; Abramczyk P; Bartoszewicz Z; Berent H; Kuczynska K
    Eur Heart J; 2005 Oct; 26(20):2166-72. PubMed ID: 15911566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon.
    Neilan TG; Januzzi JL; Lee-Lewandrowski E; Ton-Nu TT; Yoerger DM; Jassal DS; Lewandrowski KB; Siegel AJ; Marshall JE; Douglas PS; Lawlor D; Picard MH; Wood MJ
    Circulation; 2006 Nov; 114(22):2325-33. PubMed ID: 17101848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism.
    Puls M; Dellas C; Lankeit M; Olschewski M; Binder L; Geibel A; Reiner C; Schäfer K; Hasenfuss G; Konstantinides S
    Eur Heart J; 2007 Jan; 28(2):224-9. PubMed ID: 17127709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute pulmonary embolism: part II: risk stratification, treatment, and prevention.
    Goldhaber SZ; Elliott CG
    Circulation; 2003 Dec; 108(23):2834-8. PubMed ID: 14662690
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism.
    Bates SM; Ginsberg JS
    Thromb Haemost; 2000 Feb; 83(2):182-4. PubMed ID: 10739369
    [No Abstract]   [Full Text] [Related]  

  • 31. Troponin I as a marker of right ventricular dysfunction and severity of pulmonary embolism.
    Amorim S; Dias P; Rodrigues RA; Araújo V; Macedo F; Maciel MJ; Gonçalves FR
    Rev Port Cardiol; 2006 Feb; 25(2):181-6. PubMed ID: 16673648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac troponin and risk stratification in pulmonary embolism.
    Delerme S; Ray P
    Am J Emerg Med; 2008 Feb; 26(2):235-6; author reply 236-7. PubMed ID: 18272109
    [No Abstract]   [Full Text] [Related]  

  • 33. Value of ischemia-modified albumin in the diagnosis of pulmonary embolism.
    Turedi S; Gunduz A; Mentese A; Karahan SC; Yilmaz SE; Eroglu O; Nuhoglu I; Turan I; Topbas M
    Am J Emerg Med; 2007 Sep; 25(7):770-3. PubMed ID: 17870479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombolytic therapy for patients with pulmonary embolism who are hemodynamically stable but have right ventricular dysfunction: pro.
    Goldhaber SZ
    Arch Intern Med; 2005 Oct; 165(19):2197-9; discussion 2204-5. PubMed ID: 16246980
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulmonary embolism diagnosis: remember the history and physical exam.
    Goldhaber SZ
    Thromb Haemost; 2009 Jan; 101(1):7-8. PubMed ID: 19132181
    [No Abstract]   [Full Text] [Related]  

  • 36. Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis.
    Lega JC; Lacasse Y; Lakhal L; Provencher S
    Thorax; 2009 Oct; 64(10):869-75. PubMed ID: 19525265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The significance of elevated troponin levels in the absence of acute cardiac ischaemia].
    van Bockel EA; Tulleken JE; Ligtenberg JJ; van der Werf TS; Aarts LP; Zijlstra JG
    Ned Tijdschr Geneeskd; 2005 Aug; 149(34):1879-83. PubMed ID: 16136740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of B-type natriuretic peptide to predict complicated pulmonary embolism in patients aged 65 years and older: brief report.
    Ray P; Maziere F; Medimagh S; Lefort Y; Arthaud M; Duguet A; Teixeira A; Riou B
    Am J Emerg Med; 2006 Sep; 24(5):603-7. PubMed ID: 16938601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Futile D-dimer testing in hospitalized patients--description, interpretation, improvements.
    Girard P; Suresh R; Cosserat J; Czitrom D; Le Guillou JL; Leblanc I; Strauss C; Stern JB
    Thromb Haemost; 2008 Dec; 100(6):1209-11. PubMed ID: 19132254
    [No Abstract]   [Full Text] [Related]  

  • 40. An increase of BNP levels in massive pulmonary embolism and the reduction in response to the acute treatment.
    Altintop L; Yardan T; Cander B; Findik S; Yilmaz O
    Resuscitation; 2005 May; 65(2):225-9. PubMed ID: 15866405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.